Abstract
The gold standard for the diagnosis of coronavirus disease 2019 (COVID-19) is a nucleic acid detection test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which may occasionally reveal false-positive or false-negative results. Herein, we describe a case of a patient infected with human coronavirus NL63 (HCoV-NL63) who was falsely diagnosed with COVID-19 using the Ampdirect™ 2019-nCoV detection kit (Shimadzu Corporation, Japan) and SARS-CoV-2 Detection Kit (TOYOBO co., ltd.), and was admitted to a COVID-19 hospital ward. We suspected a cross-reaction between HCoV-NL63 and SARS-CoV-2; however, the reported genome sequences of HCoV-NL63 and N1/N2 primers for SARS-CoV-2 do not correspond. Thus, the PCR result was supposed to be a false positive possibly due to contamination or human error. Although the issue of a false-negative result has been the focus of much attention to prevent the spread of the disease, a false positive is fraught with problems as well. Physicians should recognize that unnecessary isolation violates human rights and a careful diagnosis is indispensable when the results of laboratory testing for COVID-19 are unclear. Generally, in cases such as a duplicate PCR test was partially positive, either N1 or N2 alone was positive, PCR testing for two or more target regions resulted in a positive only for single region, a high cycle threshold >35 was obtained, a false positive should be suspected. Especially, when these conditions coincide, we should recognize the high likelihood of a false positive.
Keywords: Coronavirus disease 2019; Human coronavirus; Severe acute respiratory syndrome coronavirus 2.
【저자키워드】 severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, human coronavirus, 【초록키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Coronavirus disease 2019, coronavirus, Human, 2019-nCoV, Diagnosis, detection, severe acute respiratory syndrome Coronavirus, Laboratory testing, Spread, nucleic acid, PCR testing, Contamination, PCR, Nucleic acid detection, cycle threshold, HCoV, Patient, Isolation, Japan, gold, NL63, PCR test, disease, False positive, false-negative, cross-reaction, False-positive, HCoV-NL63, genome sequence, Genome sequences, Human rights, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, problems, reaction, gold standard, problem, primer, issue, physician, positive, hospital ward, Prevent, likelihood, human coronavirus, reported, the disease, condition, recognize, was obtained, target region, Corporation, diagnosed with COVID-19, TOYOBO, 【제목키워드】 coronavirus, Patient, lesson, definitive diagnosis, human coronavirus, diagnosed,